Adamson, J, Lally, J, Gaughran, F, Krivoy, A, Allen, L and Stubbs, B (2017) Correlates of vitamin D in psychotic disorders: a comprehensive systematic review. Psychiatry Research 249, 78–85.
American Geriatric Society Workgroup on Vitamin D Supplementation for Older Adults (2014) Recommendations abstracted from the American geriatrics society consensus statement on vitamin D for prevention of falls and their consequences. Journal of the American Geriatric Society 62, 147–152.
Andreasen, NC, Flaum, M and Arndt, S (1992) The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry 49, 615–623.
Belvederi Murri, M, Respino, M, Masotti, M, Innamorati, M, Mondelli, V, Pariante, C and Amore, M (2013) Vitamin D and psychosis: mini meta-analysis. Schizophrenia Research 150, 235–239.
Berg, AO, Melle, I, Torjesen, PA, Lien, L, Hauff, E and Andreassen, OA (2010) A cross-sectional study of vitamin D deficiency among immigrants and Norwegians with psychosis compared to the general population. Journal of Clinical Psychiatry 71, 1598–1604.
Berg, AO, Jorgensen, KN, Nerhus, M, Athanasiu, L, Popejoy, AB, Bettella, F, Norbom, LCB, Gurholt, TP, Dahl, SR, Andreassen, OA, Djurovic, S, Agartz, I and Melle, I (2018) Vitamin D levels, brain volume, and genetic architecture in patients with psychosis. PLoS One 13, e0200250.
Boerman, R, Cohen, D, Schulte, PF and Nugter, A (2016) Prevalence of vitamin D deficiency in adult outpatients with bipolar disorder or schizophrenia. Journal of Clinical Psychopharmacology 36, 588–592.
Bruins, J, Jorg, F, van den Heuvel, ER, Bartels-Velthuis, AA, Corpeleijn, E, Muskiet, FAJ, Pijnenborg, GHM and Bruggeman, R (2017) The relation of vitamin D, metabolic risk and negative symptom severity in people with psychotic disorders. Schizophrenia Research 195, 513–518.
Cantor-Graae, E and Selten, JP (2005) Schizophrenia and migration: a meta-analysis and review. American Journal of Psychiatry 162, 12–24.
Clayton, D and Hills, M (1993) Statistical Models in Epidemiology. Oxford: Oxford University Press.
Crews, M, Lally, J, Gardner-Sood, P, Howes, O, Bonaccorso, S, Smith, S, Murray, RM, Di Forti, M and Gaughran, F (2013) Vitamin D deficiency in first episode psychosis: a case-control study. Schizophrenia Research 150, 533–537.
Davies, G, Welham, J, Chant, D, Torrey, EF and McGrath, J (2003) A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophrenia Bulletin 29, 587–593.
Dealberto, MJ (2007) Why are immigrants at increased risk for psychosis? Vitamin D insufficiency, epigenetic mechanisms, or both? Medical Hypotheses 68, 259–267.
Dealberto, MJ (2010) Ethnic origin and increased risk for schizophrenia in immigrants to countries of recent and longstanding immigration. Acta Psychiatrica Scandinavica 121, 325–339.
Dealberto, MJ (2013) Clinical symptoms of psychotic episodes and 25-hydroxy vitamin D serum levels in black first-generation immigrants. Acta Psychiatrica Scandinavica 128, 475–487.
DeLuca, GC, Kimball, SM, Kolasinski, J, Ramagopalan, SV and Ebers, GC (2013) Review: the role of vitamin D in nervous system health and disease. Neuropathology and Applied Neurobiology 39, 458–484.
Eyles, D, Burne, T and McGrath, J (2011) Vitamin D in fetal brain development. Seminars in Cell and Developmental Biology 22, 629–636.
Eyles, DW, Burne, TH and McGrath, JJ (2013) Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Frontiers in Neuroendocrinology 34, 47–64.
Eyles, DW, Trzaskowski, M, Vinkhuyzen, AAE, Mattheisen, M, Meier, S, Gooch, H, Anggono, V, Cui, X, Tan, MC, Burne, THJ, Jang, SE, Kvaskoff, D, Hougaard, DM, Norgaard-Pedersen, B, Cohen, A, Agerbo, E, Pedersen, CB, Borglum, AD, Mors, O, Sah, P, Wray, NR, Mortensen, PB and McGrath, JJ (2018) The association between neonatal vitamin D status and risk of schizophrenia. Scientific Reports 8, 17692.
Firth, J, Carney, R, Stubbs, B, Teasdale, SB, Vancampfort, D, Ward, PB, Berk, M and Sarris, J (2017) Nutritional deficiencies and clinical correlates in first-episode psychosis: a systematic review and meta-analysis. Schizophrenia Bulletin 44, 1275–1292.
Frissen, A, Lieverse, R, Drukker, M, van Winkel, R, Delespaul, P and for GROUP (2015) Childhood trauma and childhood urbanicity in relation to psychotic disorder. Social Psychiatry and Psychiatric Epidemiology 50, 1481–1488.
Frissen, A, van Os, J, Habets, P, Gronenschild, E, Marcelis, M and for GROUP (2017) No evidence of association between childhood urban environment and cortical thinning in psychotic disorder. PLoS One 12, e0166651.
Gomez, L, Stubbs, B, Shirazi, A, Vancampfort, D, Gaughran, F and Lally, J (2016) Lower bone mineral density at the hip and lumbar spine in people with psychosis versus controls: a comprehensive review and skeletal site-specific meta-analysis. Current Osteoporosis Reports 14, 249–259.
Graham, KA, Keefe, RS, Lieberman, JA, Calikoglu, AS, Lansing, KM and Perkins, DO (2015) Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia. Early Intervention in Psychiatry 9, 397–405.
Hedelin, M, Lof, M, Olsson, M, Lewander, T, Nilsson, B, Hultman, CM and Weiderpass, E (2010) Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33000 women from the general population. BMC Psychiatry 10, 38.
Humble, MB (2010) Vitamin D, light and mental health. Journal of Photochemistry and Photobiology B 101, 142–149.
Humble, MB, Gustafsson, S and Bejerot, S (2010) Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with season, age, ethnic origin and psychiatric diagnosis. Journal of Steroid Biochemistry and Molecular Biology 121, 467–470.
Itzhaky, D, Amital, D, Gorden, K, Bogomolni, A, Arnson, Y and Amital, H (2012) Low serum vitamin D concentrations in patients with schizophrenia. Israel Medical Association Journal 14, 88–92.
Ju, SY, Lee, YJ and Jeong, SN (2013) Serum 25-hydroxyvitamin D levels and the risk of depression: a systematic review and meta-analysis. Journal of Nutrition, Health and Aging 17, 447–455.
Kay, SR, Fiszbein, A and Opler, LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261–276.
Kinney, DK, Teixeira, P, Hsu, D, Napoleon, SC, Crowley, DJ, Miller, A, Hyman, W and Huang, E (2009) Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections? Schizophrenia Bulletin 35, 582–595.
Kirkbride, JB and Jones, PB (2011) The prevention of schizophrenia--what can we learn from eco-epidemiology? Schizophrenia Bulletin 37, 262–271.
Korver, N, Quee, PJ, Boos, HB, Simons, CJ, de Haan, L and for GROUP (2012) Genetic Risk and Outcome of Psychosis (GROUP), a multi-site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods. International Journal of Methods in Psychiatric Research 21, 205–221.
Krivoy, A, Onn, R, Vilner, Y, Hochman, E, Weizman, S, Paz, A, Hess, S, Sagy, R, Kimhi-Nesher, S, Kalter, E, Friedman, T, Friedman, Z, Bormant, G, Trommer, S, Valevski, A and Weizman, A (2017) Vitamin D supplementation in chronic schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled clinical trial. EBioMedicine 26, 138–145.
Lally, J, Gardner-Sood, P, Firdosi, M, Iyegbe, C, Stubbs, B, Greenwood, K, Murray, R, Smith, S, Howes, O and Gaughran, F (2016) Clinical correlates of vitamin D deficiency in established psychosis. BMC Psychiatry 16, 76.
Lippi, G, Bonelli, P, Buonocore, R and Aloe, R (2015) Birth season and vitamin D concentration in adulthood. Annals of Translational Medicine 3, 231.
McGrath, J (1999) Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophrenia Research 40, 173–177.
McGrath, J, Eyles, D, Mowry, B, Yolken, R and Buka, S (2003) Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. Schizophrenia Research 63, 73–78.
McGrath, JJ, Eyles, DW, Pedersen, CB, Anderson, C, Ko, P, Burne, TH, Norgaard-Pedersen, B, Hougaard, DM and Mortensen, PB (2010) Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Archives of General Psychiatry 67, 889–894.
Mendes, MM, Darling, AL, Hart, KH, Morse, S, Murphy, RJ and Lanham-New, SA (2019) Impact of high latitude, urban living and ethnicity on 25-hydroxyvitamin D status: a need for multidisciplinary action? The Journal of Steroid Biochemistry and Molecular Biology 188, 95–102.
Menkes, DB, Lancaster, K, Grant, M, Marsh, RW, Dean, P and du Toit, SA (2012) Vitamin D status of psychiatric inpatients in New Zealand's Waikato region. BMC Psychiatry 12, 68.
Nerhus, M, Berg, AO, Dahl, SR, Holvik, K, Gardsjord, ES, Weibell, MA, Bjella, TD, Andreassen, OA and Melle, I (2015) Vitamin D status in psychotic disorder patients and healthy controls--The influence of ethnic background. Psychiatry Research 230, 616–621.
Nerhus, M, Berg, AO, Kvitland, LR, Dieset, I, Hope, S, Dahl, SR, Weibell, MA, Romm, KL, Faerden, A, Andreassen, OA and Melle, I (2016) Low vitamin D is associated with negative and depressive symptoms in psychotic disorders. Schizophrenia Research 178, 44–49.
Partti, K, Heliovaara, M, Impivaara, O, Perala, J, Saarni, SI, Lonnqvist, J and Suvisaari, JM (2010) Skeletal status in psychotic disorders: a population-based study. Psychosomatic Medicine 72, 933–940.
Pedersen, CB and Mortensen, PB (2001) Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Archives of General Psychiatry 58, 1039–1046.
Reininghaus, U, Dutta, R, Dazzan, P, Doody, GA, Fearon, P, Lappin, J, Heslin, M, Onyejiaka, A, Donoghue, K, Lomas, B, Kirkbride, JB, Murray, RM, Croudace, T, Morgan, C and Jones, PB (2015) Mortality in schizophrenia and other psychoses: a 10-year follow-up of the SOP first-episode cohort. Schizophrenia Bulletin 41, 664–673.
Saha, S, Chant, DC, Welham, JL and McGrath, JJ (2006) The incidence and prevalence of schizophrenia varies with latitude. Acta Psychiatrica Scandinavica 114, 36–39.
Salavert, J, Grados, D, Ramiro, N, Carrion, MI, Fadeuilhe, C, Palma, F, Lopez, L, Erra, A and Ramirez, N (2017) Association between vitamin D Status and schizophrenia: a first psychotic episode study. Journal of Nervous and Mental Disease 205, 409–412.
Suetani, S, Saha, S, Eyles, DW, Scott, JG and McGrath, JJ (2017) Prevalence and correlates of suboptimal vitamin D status in people living with psychotic disorders: data from the Australian Survey of High Impact Psychosis. Australian and New Zealand Journal of Psychiatry 51, 921–929.
Sullivan, S, Wills, A, Lawlor, D, McGrath, J and Zammit, S (2013) Prenatal vitamin D status and risk of psychotic experiences at age 18years-a longitudinal birth cohort. Schizophrenia Research 148, 87–92.
Taylor, AE, Burgess, S, Ware, JJ, Gage, SH, Richards, JB, Davey Smith, G and Munafo, MR (2016) Investigating causality in the association between 25(OH)D and schizophrenia. Scientific Reports 6, 26496.
Valipour, G, Saneei, P and Esmaillzadeh, A (2014) Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies. Journal of Clinical Endocrinology and Metabolism 99, 3863–3872.
van Mierlo, HC, de Witte, L, Derksen, RH, Otten, HG and for GROUP (2015) The prevalence of antinuclear antibodies in patients with schizophrenia spectrum disorders: results from a large cohort study. NPJ Schizophrenia 1, 15013.
Veling, W, Hoek, HW, Selten, JP and Susser, E (2011) Age at migration and future risk of psychotic disorders among immigrants in the Netherlands: a 7-year incidence study. American Journal of Psychiatry 168, 1278–1285.
Yee, JY, See, YM, Abdul Rashid, NA, Neelamekam, S and Lee, J (2016) Association between serum levels of bioavailable vitamin D and negative symptoms in first-episode psychosis. Psychiatry Research 243, 390–394.
Yoo, T, Choi, W, Hong, JH, Lee, JY, Kim, JM, Shin, IS, Yang, SJ, Amminger, P, Berk, M, Yoon, JS and Kim, SW (2018) Association between vitamin D insufficiency and metabolic syndrome in patients with psychotic disorders. Psychiatry Investigation 15, 396–401.
Yuksel, RN, Altunsoy, N, Tikir, B, Cingi Kuluk, M, Unal, K, Goka, S, Aydemir, C and Goka, E (2014) Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation. Therapeutic Advances in Psychopharmacology 4, 268–275.
Zhu, DM, Liu, Y, Zhang, AG, Chu, ZX, Wu, Q, Li, H, Ge, JF, Dong, Y and Zhu, P (2015) High levels of vitamin D in relation to reduced risk of schizophrenia with elevated C-reactive protein. Psychiatry Research 228, 565–570.